Liverpool summer revamp inevitable as transfer question emerges after three players denied starts
Ian Doyle considers the main Liverpool talking points after the dire Carabao Cup final defeat against Newcastle United at Wembley ...
Echo Report Analyzes League Cup Final Lineup: Jota & Nunez in Poor Form, Diaz to Play as Center Forward
Liverpool will face Newcastle United in the highly anticipated League Cup final. The clash is set to kick off at 0:30 Beijing time, and the Liverpool Echo has undertaken a detailed analysis of ...
OneFootball5d
Gravenberch on decision to listen to doctors orders at sit out with ‘so much pain’ at Wembley | OneFootball
Paul Merson has called for some squad rotation for the match, though many will be very confident that this won’t involve the ...
Wednesday’s analyst upgrades and downgrades
After the bell on Monday, the Markham, Ont.-based software company revealed quarterly revenue of $124-million, up 2.9 per ...
Yardbarker on MSN4d
Gravenberch on decision to listen to doctors orders at sit out with ‘so much pain’ at Wembley
Liverpool are preparing for a cup final once again this weekend and one man desperate to make an impact is Ryan Gravenberch.
Football Talk2d
Liverpool vs Newcastle United preview: Carabao Cup final showdown at Wembley
Liverpool will aim to win a record 11th Carabao Cup title when they face Newcastle United in the final on Sunday at Wembley ...
FiercePharma4d
Mallinckrodt, Endo look to carve out brighter future through $6.7B merger
Under the agreement, Endo shareholders are slated to receive a total of $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will have a 50.1% piece of the pie.
MedCity News5d
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...